Award notice Supplies
Produkty farmaceutyczne
Notice published in Polish. The AI analysis summarises it for you in your language.
- Public buyer
- Mazowieckie Centrum Leczenia Chorób Płuc i Gruźlicy
Otwock - Place of performance
- Otwock
- Planned end of contract
- 7 September 2027
likely re-tender around March 2027 - Bids received
- 6
- Procedure
- Open procedure
Any company may submit a bid. - Publication
- 16 September 2026
- Notice language
- Polish
AI analysis: go for it or not?
Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.
Unlimited analyses during the 14-day Pro trial, no card needed.
Description
Produkty farmaceutyczne - 14 pakietów
Awarded to
14 lots
- Tislelizumab
- Serplulimab
- Tremelimumab
- Ipilimumab
- Ozymertynib
- Amivantamab
- Lazertinib
- Binimetinim
- Encoafenib
- Nitendanib
- Cemiplimab
- Durvalumab
- Entrektynib
- Vincristina
CPV codes
European codes that classify what the contract is about. They are how we find the tenders for your trade.
33600000
Similar contracts already awarded
Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 636871-2026.